Evidence map›Paper›PMID 27417446›Full record

ReviewDrugs & aging2016

Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.

Sita Chokhavatia, Elizabeth S John, Mary Barna Bridgeman, Deepali Dixit

Open access · hybridAbstract readReview
In one paragraph

Review in Drugs & aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sita ChokhavatiaDivision of Gastroenterology and Hepatology, Rutgers, Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, MEB Room 478C, New Brunswick, NJ, 08901, USA. sita.chokhavatia@rutgers.edu.
Elizabeth S JohnDivision of Gastroenterology and Hepatology, Rutgers, Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, MEB Room 478C, New Brunswick, NJ, 08901, USA.
Mary Barna BridgemanErnest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Deepali DixitErnest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Robert Wood Johnson University Hospital · USJohnson University · USRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Constipation is a common and often debilitating condition in the elderly, which may be caused by underlying disease conditions, structural abnormalities in the bowel, and a variety of medications such as anticholinergics, antidepressants, and opiates. In this review, we focus on opioid-induced constipation (OIC), which is often underrecognized and undertreated in the elderly. When opioid therapy is initiated, healthcare providers are encouraged to evaluate risk factors for the development of constipation as part of a thorough patient history. To this end, the patient assessment should include the use of validated instruments, such as the Bristol Stool Scale and Bowel Function Index, to confirm the diagnosis and provide a basis for evaluating treatment outcomes. Healthcare providers should use a stepwise approach to the treatment of OIC in the elderly. Conventional laxatives are a first-line option and considered well tolerated with short-term use as needed; however, evidence is lacking to support their effectiveness in OIC. Moreover, because of the risk of adverse events and other considerations, such as chewing difficulties and swallowing disorders, conventional oral laxatives may be inappropriate for the treatment of OIC in the elderly. Thus, the availability of new pharmacologic agents such as the peripherally acting µ-opioid receptor antagonists methylnaltrexone and naloxegol, which target the underlying causes of OIC, and the secretagogue lubiprostone may provide more effective treatment options for elderly patients with OIC.

Indexed as

AgedAnalgesics, OpioidConstipationHealth PersonnelHumansLaxativesNaltrexoneNarcotic AntagonistsPainQuaternary Ammonium CompoundsReceptors, Opioid, muTreatment OutcomeAnalgesics, OpioidLaxativesmethylnaltrexoneNaltrexoneNarcotic AntagonistsQuaternary Ammonium CompoundsReceptors, Opioid, mu

Identifiers

PMID27417446
PMCPMC5012150
OpenAlexW2460976321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.